Clinical Trial Detail

NCT ID NCT04163432
Title Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC (STAGGER)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Utah
Indications

lung non-squamous non-small cell carcinoma

Therapies

Carboplatin + Durvalumab + Pemetrexed Disodium

Durvalumab + Pemetrexed Disodium

Age Groups: adult senior

Additional content available in CKB BOOST